Antimicrobial resistance and sepsis are inherently interconnected issues, but are campaigns for antibiotic stewardship competing against sepsis awareness campaigns with regards to their messages on antibiotic use?
Browsing: Clinical > Clinical Diseases
In this interview, we spoke to Yoav Golan about recent developments in the field of Clostridium difficile infections – from the latest clinical trial results to newly updated guidelines.
In this interview we speak to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance.
Researchers at Stanford University School of Medicine have reported that the most common origin of bloodstream infections, during a hospital stay, as a consequence of the patient’s own gut.
In this infographic we take a look at the estimated burden of healthcare-associated infections in acute care hospitals across Europe.
In this interview with Trisha Peel from Monash University, she explains the issues surrounding device-related infections in addition to discussing some promising new approaches to diagnosis and treatment.
Merck’s antibiotic ZERBAXA® (ceftolozane and tazobactam) has met its primary endpoint of non-inferiority compared with meropenem in a Phase III trial of patients with hospital-acquired and ventilator-associated bacterial pneumonia.
We speak to infectious diseases specialist, Ellie Goldstein (Santa Monica, CA, USA), about his recent publication on real world data and the challenges facing drug-resistant infections.
A study in 20 patients has demonstrated that transplantation followed by antiviral therapy has been successful in patients receiving kidneys from hepatitis C-infected donors.
Whole-genome sequencing has been used to demonstrate that carbapenem resistance can be transferred among unrelated bacteria species in a healthcare setting.